What's a fair offer from Pfizer?, page-32

Hi TT, as well as @aras, @AlCp and @MrAdem. Thanks for your responses.

I get where you are all coming from, but the original point still stands. ResApp may indeed have great future revenue prospects etc, but Pfizer aren't offering to buy them at some stage far in the future when all of that is realised - they are offering to buy them now: when RAP look like they have great tech, but no cash, and no way to quickly monetise the tech, and therefore no revenue.

Pfizer are offering a premium already far above what the rest of the sharemarket was willing to pay at this very point in time. I'm not saying it's perfectly fair, or that holders should be happy (quite the opposite - the SP is down here because progress has been so snail-like). But at the same time, the pragmatist in me can understand why ResApp management are sort of saying "well, if you think we're worth so much more than 11.5c a share *at this precise moment in time* then why haven't you bid up the price on-market prior to this deal breaking?"

Not here to sledge, as I said the fact Pfizer want to buy it appears to be a great endorsement - but expectations seem totally out of whack with reality. PS: I say all of this as someone who only invests - I buy and hold, I don't trade.